An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Medical clinics in the western Bay of Plenty area are experiencing a spike in people presenting with influenza and Covid-19 ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Australia's vaccination rates against COVID and influenza are below ideal figures, but could a future innovation be able to ...

PRN02047 To: integrated care boards – chief executives GP practices community pharmacies primary care networks NHS trusts – chief executives local government chief executives health and justice ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

Solid phase III efficacy results for Moderna Inc.’s seasonal influenza vaccine, mRNA-1010, may lead the company to resubmit a ...

Monitoring fungal spores in the outdoor air can predict surges in flu and COVID-19 infections, especially during the fall, ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...